+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach



Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach



La Radiologia Medica 101(5): 382-385



To evaluate a patient population affected by Neurofibromatosis type 1 (NF1) with special reference to optic pathway gliomas. A total of 419 NF1 patients (222 men, 197 women) were retrospectively evaluated to show incidence, biological behaviour, neuroradiological and clinical presentation of optic pathway gliomas. Central Nervous System MR and ophthalmologic evaluations were reviewed. Thirty-two patients out of 419 (7.6%) showed the presence of optic pathway gliomas. Of these, 28 (87.2%) patients showed tumoral involvement of the optic chiasma. The right intracranial optic nerve was involved in 15 patients (46.8%), the left intracranial optic nerve in 18 (56.2%), the right extracranial optic nerve in 11 (34.3%), the left extracranial optic nerve in 10 (31.2%) and the right and left optic tracts in 6 (18.7%) patients. Geniculate body and optic radiation were not involved by tumour diffusion. Visual acuity testing was positive in 26/32 (81.2%), the fundus oculi in 11/32 (34.3%) patients and the visual field evaluation in 12/32 (37.5%) patients. In this study we showed an high correlation between optic pathway tumours and ophthalmologic abnormalities confirming the usefulness of an integrated clinical-neuroradiological approach in patients affected by NF1. We also described the biological behaviour of these tumours in our NF1 patient population.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046870909

Download citation: RISBibTeXText

PMID: 11438792


Related references

Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients. Revista de Neurologia 46(9): 530-536, 2008

Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111(3): 568-577, 2004

Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Journal of Aapos 14(2): 155-158, 2010

Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. Journal of Neuro-Oncology 129(1): 173-178, 2016

Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. Neuro-Oncology 15(8): 1088-1095, 2013

Optic Pathway Gliomas in Neurofibromatosis Type 1. Journal of Child Neurology 33(1): 73-81, 2018

Optic pathway gliomas in children with neurofibromatosis type 1. IOVS 40(4): S916, 1999

Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1. Seminars in Pediatric Neurology 24(2): 92-99, 2017

Optic Pathway Gliomas in Neurofibromatosis Type 1: Imaging and Monitoring. International Ophthalmology Clinics 58(4): 97, 2018

Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 25(6): 295-300, 1994

Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 100(4): 667-670, 1997

Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?. Child's Nervous System 27(12): 2107-2111, 2011

Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas. Familial Cancer 11(4): 653-656, 2012

Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. American Journal of Medical Genetics. Part a 122a(2): 95-99, 2003

Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1. Pediatric Blood and Cancer 57(4): 688, 2011